A team of researchers has reported an important advance in the search for better treatments for advanced prostate cancer.

Vir Biotechnology has reported positive updated Phase 1 results for VIR-5500, an experimental pill-form therapy targeting metastatic prostate cancer that researchers have called “stunning.” The drug, ...

Chicago,IL, Nov. 07, 2020 (GLOBE NEWSWIRE) -- There is a press release, dated October 23, 2020, concerning the formula. According to the press release, “Vitalflow is a triple-action supplement that ...

CHICAGO -- There is more evidence that taking vitamin E pills can be risky. A study that followed up on men who took high doses of the vitamin for about five years found they had a slightly increased ...

Most men's supplement brands look identical on the shelf. And that's exactly the problem. Proprietary blends hide dosage details, marketing claims outrun the science, and third-party testing gets ...

CHICAGO, June 4 (Reuters) - A chemotherapy pill to treat advanced prostate cancer that had failed to respond to conventional treatments was successful in reducing the risk of disease progression, ...

Researchers say a cheap, generic pill called finasteride prevents almost 40 percent of low-grade prostate cancers without increasing the risk of dying from more aggressive tumors. New evidence points ...

One in six men will be diagnosed with prostate cancer. If the cancer spreads, treatment options start to dwindle, but a new pill is offering some men new hope.